Literature DB >> 14679260

Acarbose for patients with hypertension and impaired glucose tolerance.

Thomas Kaiser, Peter T Sawicki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14679260     DOI： 10.1001/jama.290.23.3066-b

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  3 in total

1.  Response to Chiasson et al.: Acarbose for the prevention of Type 2 diabetes, hypertension and cardiovascular disease in subjects with impaired glucose tolerance: facts and interpretations concerning the critical analysis of the STOP-NIDDM Trial data.

Authors:  P T Sawicki; T Kaiser
Journal:  Diabetologia       Date:  2004-05-19       Impact factor: 10.122

2.  Alpha-glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus.

Authors:  Suzanne Vl Moelands; Peter Lbj Lucassen; Reinier P Akkermans; Wim Jc De Grauw; Floris A Van de Laar
Journal:  Cochrane Database Syst Rev       Date:  2018-12-28

Review 3.  On the potential of acarbose to reduce cardiovascular disease.

Authors:  Eberhard Standl; Michael J Theodorakis; Michael Erbach; Oliver Schnell; Jaakko Tuomilehto
Journal:  Cardiovasc Diabetol       Date:  2014-04-16       Impact factor: 9.951
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.